Tumor microbial burden drives immune responses through regulation of Interferon signaling.

Saved in:
Bibliographic Details
Title: Tumor microbial burden drives immune responses through regulation of Interferon signaling.
Authors: Liu H; The University of Texas MD Anderson Cancer Center Houston United States., Jang JH; Seoul National University Seoul Korea (South), Republic of., Peng F; The University of Texas MD Anderson Cancer Center Houston, TX United States., Rajaei H; The University of Texas MD Anderson Cancer Center Houston United States., Chandra V; The University of Texas MD Anderson Cancer Center Houston United States., Li L; The University of Texas MD Anderson Cancer Center Houston, Texas United States., Rupani DN; UT MD Anderson Cancer Center Houston United States., Taghinezhadsaroukalaei S; The University of Texas MD Anderson Cancer Center Houston United States., Zhao Y; The University of Texas MD Anderson Cancer Center Houston, TX United States., Faraoni EY; The University of Texas MD Anderson Cancer Center Houston, TX United States., Bartelli TF; The University of Texas MD Anderson Cancer Center Houston, TX United States., Le Roux O; The University of Texas MD Anderson Cancer Center Houston United States., Tahan V; The University of Texas MD Anderson Cancer Center Houston United States., Jimenez-Arancon F; The University of Texas MD Anderson Cancer Center Houston United States., Baydogan S; University of Texas MD Anderson Cancer Center Houston United States., Mohseni AH; The University of Texas MD Anderson Cancer Center Houston, TX United States., Gomez JA; The University of Texas MD Anderson Cancer Center Houston, TX United States., Patel M; Memorial Sloan Kettering Cancer Center New York, New York United States., Burks JK; The University of Texas MD Anderson Cancer Center Houston, TX United States., Miño Galvez B; Clínica Alemana Santiago Chile., Carvajal-Hausdorf DE; Clinica Alemana Facultad de Medicina Universidad del Desarrollo Santiago, RM Chile., Ruiz-García E; Instituto Nacional de Cancerología mexico Mexico., Fernandez-Figueroa EA; National Institute of Genomic Medicine mexico, mexico Mexico., Kopetz S; University of Texas MD Anderson Cancer Center Houston, TX United States., Maron SB; Memorial Sloan Kettering Cancer Center New York, NY United States., Cercek A; Memorial Sloan Kettering Cancer Center New York, NY United States., Riquelme EM; Pontificia Universidad Católica de Chile SANTIAGO, SANTIAGO Chile., Navin NE; UT-MD Anderson Cancer Center Houston, Texas United States., White JR; Resphera Biosciences Baltimore, MD United States., Wang L; The University of Texas MD Anderson Cancer Center Houston, Texas United States., Diaz LA; Memorial Sloan Kettering Cancer Center New York, NY United States., McAllister F; The University of Texas MD Anderson Cancer Center Houston United States.
Source: Cancer discovery [Cancer Discov] 2026 Jun 26. Date of Electronic Publication: 2026 Jun 26.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-24-1908